News

Latest

The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies for sickle cell disease to apply through May 1 to participate in the Cell and Gene Therapy Access Model.
Deborah Brown, senior vice president of external and regulatory affairs at NYC Health + Hospitals, discusses common challenges for metropolitan anchor hospitals and why these hospitals need more federal recognition and support.
The House March 5 voted 382-12 to pass the AHA-supported Preventing Maternal Deaths Reauthorization Act (H.R. 3838), bipartisan legislation that would reauthorize federal support for state-based committees that review pregnancy-related deaths to identify causes and make recommendations to prevent future mortalities.
The House Ways and Means Committee March 6 voted 26-17 to advance as amended to the full House the Protecting America’s Seniors’ Access to Care (H.R. 7513), AHA-supported legislation that would prohibit the Centers for Medicare & Medicaid Services from finalizing a proposed rule on minimum staffing for long-term care facilities.
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains certain health care provisions of interest to hospitals. The Senate is expected to consider the legislation later this week.
by Rick Pollack, President and CEO, AHA
We continue to press Congress, the Administration and UnitedHealth Group to step up their efforts to respond to this unprecedented incident.
The Centers for Medicaid & Medicare Services March 5 announced flexibilities intended to help providers continue to serve patients in the wake of the cyberattack on Change Healthcare.
The Justice Department’s Antitrust Division, Federal Trade Commission and Department of Health and Human Services seek public input through May 6 on increasing private-equity and other corporate ownership in health care, which will inform their future enforcement priorities and efforts to promote competition in health care markets.
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19.
The House and Senate Appropriations Committees March 3 released a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains certain health care provisions of interest to hospitals.